Shandong Polymer Biochemicals Co., Ltd.
Simbolis: 002476.SZ
SHZ
4.61
CNYRinkos kaina šiandien
-1078.4464
P/E santykis
12.5889
PEG koeficientas
2.82B
MRK kapitalizacija
- 0.00%
DIV pajamingumas
Shandong Polymer Biochemicals Co., Ltd. (002476-SZ) Finansinės ataskaitos
Balansas
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 1259.11 | 305.6 | 401 | 361.8 | ||||||||||||||||
balance-sheet.row.short-term-investments | 0.31 | 0.3 | 0 | -18.6 | ||||||||||||||||
balance-sheet.row.net-receivables | 1010.97 | 365.1 | 248.1 | 127.9 | ||||||||||||||||
balance-sheet.row.inventory | 426.51 | 84.5 | 82 | 65.7 | ||||||||||||||||
balance-sheet.row.other-current-assets | 15.57 | 6.6 | 24.1 | 13.5 | ||||||||||||||||
balance-sheet.row.total-current-assets | 2712.15 | 761.7 | 755.1 | 568.9 | ||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 745.39 | 182.4 | 200.8 | 390 | ||||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.intangible-assets | 441.88 | 10.2 | 10.7 | 11.3 | ||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 441.88 | 10.2 | 10.7 | 11.3 | ||||||||||||||||
balance-sheet.row.long-term-investments | 278.39 | 79.5 | 8.5 | 31.5 | ||||||||||||||||
balance-sheet.row.tax-assets | 20.63 | 5.8 | 6.5 | 7.1 | ||||||||||||||||
balance-sheet.row.other-non-current-assets | 24.19 | 0.4 | 10.8 | 1.2 | ||||||||||||||||
balance-sheet.row.total-non-current-assets | 1510.49 | 278.2 | 237.3 | 441.1 | ||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.total-assets | 4222.64 | 1040 | 992.4 | 1010.1 | ||||||||||||||||
balance-sheet.row.account-payables | 262.9 | 134.6 | 63.1 | 58.5 | ||||||||||||||||
balance-sheet.row.short-term-debt | 60.91 | 11.4 | 1.4 | 43.1 | ||||||||||||||||
balance-sheet.row.tax-payables | 14.29 | 3.2 | 3.9 | 2.1 | ||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 0 | 0.1 | 77.9 | ||||||||||||||||
Deferred Revenue Non Current | 4.77 | 1.3 | 1.5 | 1.7 | ||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0.34 | - | - | - | ||||||||||||||||
balance-sheet.row.other-current-liab | 40.68 | 22.8 | 12 | 0.5 | ||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 5.11 | 1.3 | 1.7 | 79.6 | ||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.capital-lease-obligations | 2.3 | 1.4 | 0.1 | 77.9 | ||||||||||||||||
balance-sheet.row.total-liab | 497.51 | 170.4 | 152.4 | 188 | ||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.common-stock | 2448 | 612 | 612 | 612 | ||||||||||||||||
balance-sheet.row.retained-earnings | 108.28 | 29.1 | -0.5 | -18.5 | ||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 568.62 | 53.5 | 53.5 | 53.5 | ||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 349.96 | 175 | 175 | 175 | ||||||||||||||||
balance-sheet.row.total-stockholders-equity | 3474.86 | 869.6 | 840 | 822 | ||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 4222.64 | 1040 | 992.4 | 1010.1 | ||||||||||||||||
balance-sheet.row.minority-interest | 250.28 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.total-equity | 3725.13 | 869.6 | 840 | 822 | ||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 4222.64 | - | - | - | ||||||||||||||||
Total Investments | 278.39 | 79.5 | 8.5 | 12.9 | ||||||||||||||||
balance-sheet.row.total-debt | 60.91 | 11.4 | 1.6 | 43.1 | ||||||||||||||||
balance-sheet.row.net-debt | -1198.2 | -294.2 | -399.4 | -318.8 |
Pinigų srautų ataskaita
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -2.07 | 29.6 | 17.9 | 13.2 | ||||||||||||||||
cash-flows.row.depreciation-and-amortization | 9.59 | 34.9 | 38.8 | 40.6 | ||||||||||||||||
cash-flows.row.deferred-income-tax | 0.69 | 0.7 | -0.2 | 3.9 | ||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | -0.7 | 0.2 | -3.9 | ||||||||||||||||
cash-flows.row.change-in-working-capital | -164.92 | -153.9 | -101.8 | -33.6 | ||||||||||||||||
cash-flows.row.account-receivables | -161.99 | -162 | -206.5 | -52.2 | ||||||||||||||||
cash-flows.row.inventory | -2.92 | -2.9 | -15.9 | 25.2 | ||||||||||||||||
cash-flows.row.account-payables | 0 | 10.3 | 120.9 | -10.5 | ||||||||||||||||
cash-flows.row.other-working-capital | 0 | 0.7 | -0.2 | 3.9 | ||||||||||||||||
cash-flows.row.other-non-cash-items | 108.17 | 11.2 | 10.2 | 12.3 | ||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 104.27 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -11.7 | -15 | -19.2 | -17.7 | ||||||||||||||||
cash-flows.row.acquisitions-net | -71.17 | 5.5 | 117.5 | 2.4 | ||||||||||||||||
cash-flows.row.purchases-of-investments | -40 | -80 | 0.3 | 0 | ||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 1.9 | 1.9 | 22.6 | 0 | ||||||||||||||||
cash-flows.row.other-investing-activites | -65.64 | 0.9 | -1.7 | 24.1 | ||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -117.35 | -86.7 | 119.5 | 8.8 | ||||||||||||||||
cash-flows.row.debt-repayment | -21.82 | -9.9 | -30.3 | -67 | ||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.dividends-paid | -0.57 | -0.4 | -5.7 | -10.4 | ||||||||||||||||
cash-flows.row.other-financing-activites | 24.81 | 17.7 | -12 | 7 | ||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 4.15 | 7.3 | -48 | -70.5 | ||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0.91 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.net-change-in-cash | -8.02 | -157.6 | 36.6 | -29.1 | ||||||||||||||||
cash-flows.row.cash-at-end-of-period | 1184.3 | 240.6 | 398.2 | 361.5 | ||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 1192.32 | 398.2 | 361.5 | 390.7 | ||||||||||||||||
cash-flows.row.operating-cash-flow | 104.27 | -78.2 | -34.8 | 32.5 | ||||||||||||||||
cash-flows.row.capital-expenditure | -11.7 | -15 | -19.2 | -17.7 | ||||||||||||||||
cash-flows.row.free-cash-flow | 92.56 | -93.2 | -54 | 14.9 |
Pajamų ataskaitos eilutė
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 479.79 | 592.3 | 657.2 | 447.3 | ||||||||||||||||
income-statement-row.row.cost-of-revenue | 384.21 | 462.7 | 557.1 | 363.6 | ||||||||||||||||
income-statement-row.row.gross-profit | 95.58 | 129.6 | 100.1 | 83.7 | ||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||
income-statement-row.row.research-development | 18.04 | - | - | - | ||||||||||||||||
income-statement-row.row.selling-general-administrative | 11.99 | - | - | - | ||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 26.25 | - | - | - | ||||||||||||||||
income-statement-row.row.other-expenses | 39.57 | 41.2 | 28.9 | 19.7 | ||||||||||||||||
income-statement-row.row.operating-expenses | 98.38 | 100.8 | 76.8 | 58.2 | ||||||||||||||||
income-statement-row.row.cost-and-expenses | 482.59 | 563.5 | 633.9 | 421.9 | ||||||||||||||||
income-statement-row.row.interest-income | 6.13 | 6.7 | 5.4 | 5.6 | ||||||||||||||||
income-statement-row.row.interest-expense | 0.58 | 0.5 | 4.7 | 9.7 | ||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 26.25 | - | - | - | ||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 2.98 | 0.3 | -7.6 | -9.8 | ||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.other-operating-expenses | 39.57 | 41.2 | 28.9 | 19.7 | ||||||||||||||||
income-statement-row.row.total-operating-expenses | 2.98 | 0.3 | -7.6 | -9.8 | ||||||||||||||||
income-statement-row.row.interest-expense | 0.58 | 0.5 | 4.7 | 9.7 | ||||||||||||||||
income-statement-row.row.depreciation-and-amortization | -4.07 | 36.9 | 38.8 | 40.6 | ||||||||||||||||
income-statement-row.row.ebitda-caps | -4.59 | - | - | - | ||||||||||||||||
income-statement-row.row.operating-income | -0.52 | 30.7 | 25.3 | 26.8 | ||||||||||||||||
income-statement-row.row.income-before-tax | -2.13 | 31.1 | 17.7 | 17.1 | ||||||||||||||||
income-statement-row.row.income-tax-expense | -0.07 | 1.4 | -0.2 | 3.9 | ||||||||||||||||
income-statement-row.row.net-income | -2.07 | 29.6 | 17.9 | 13.2 |
Dažnai užduodami klausimai
Kas yra Shandong Polymer Biochemicals Co., Ltd. (002476.SZ) bendras turtas?
Shandong Polymer Biochemicals Co., Ltd. (002476.SZ) bendras turtas yra 1039968863.000.
Kokios yra įmonės metinės pajamos?
Metinės pajamos yra 212096636.000.
Kokia yra įmonės pelno marža?
Įmonės pelno marža yra 0.199.
Koks yra įmonės laisvųjų pinigų srautas?
Laisvųjų pinigų srautas yra 0.151.
Kokia yra įmonės grynojo pelno marža?
Grynojo pelno marža yra -0.004.
Kokios yra bendros įmonės pajamos?
Bendrosios pajamos yra -0.001.
Kas yra Shandong Polymer Biochemicals Co., Ltd. (002476.SZ) grynasis pelnas (grynosios pajamos)?
Grynasis pelnas (grynosios pajamos) yra 29630378.000.
Kokia yra bendra įmonės skola?
Bendra skola yra 11381167.000.
Koks yra veiklos sąnaudų skaičius?
Veiklos sąnaudos yra 100833128.000.
Koks yra įmonės grynųjų pinigų skaičius?
Įmonės grynieji pinigai yra 314019731.000.